Skip to main content
SpringerLink
Log in

Evaluation of a single intravitreal injection of dexamethasone phosphate in vitrectomy surgery for diabetic retinopathy complications

  • Clinical Investigations
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

For evaluation of the efficacy and toxicity of dexamethasone phosphate after pars plana vitrectomy, 27 randomly selected eyes received 0.8 mg intravitreal dexamethasone phosphate and 30 control eyes did not receive this injection. No signs of dexamethasone phosphate toxicity were observed during 6 months of followup evaluations. Visual acuities of 20/40 or better were obtained in 26% of the dexamethasone-treated group and 33% of the control group, and those of 20/200 or better were obtained in 74% of the dexamethasone-treated eyes and 73% of the control eyes. Moderate anterior chamber flare or fibrin formation occurred in only 15% of the dexamethasone-treated eyes but in 27% of the control eyes one day after surgery. Lens changes occurred equally in both groups. None of the eyes in either group developed substantial intraocular proliferation or membranes following surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Blankenship GW (1989) Evaluation of a single intravitreal injection of 5-fluorouracil in vitrectomy cases. Graefe's Arch Clin Exp Ophthalmol 227:565–568

    Google Scholar 

  2. Blankenship GW, Friedland BR, Blumenkranz M (1986) Ocular effects and clearance of intravitreal 5-fluorouracil. In: Blankenship GW, Binder S, Gonvers M, Stirpe M (eds) Basic and advanced vitreous surgery. Springer, Berlin Heidelberg New York, pp 415–419

    Google Scholar 

  3. Chandler DB, Rozakis G, Juan E de, Machemer R (1985) The effect of triamcinolone acetonide on a refined experimental model of proliferative vitreoretinopathy. Am J Ophthalmol 99:686–690

    Google Scholar 

  4. Chandler DB, Hida T, Sheta SM, Proia AD, Machemer R (1987) Improvement in efficacy of corticosteroid therapy in an animal model of proliferative vitreoretinopathy by pretreatment. Graefe's Arch Clin Exp Ophthalmol 225:259–265

    Google Scholar 

  5. Faulborn J, Conway BP, Machemer R (1978) Surgical complications of pars plana vitreous surgery. Ophthalmology 85:116–125

    Google Scholar 

  6. Graham RO, Peyman GA (1974) Intravitreal injection of dexamethasone. Treatment of experimentally induced endophthalmitis. Arch Ophthalmol 92:149–155

    Google Scholar 

  7. Hida T, Chandler C, Arena JE, Machemer R (1986) Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations. Am J Ophthalmol 101:190–195

    Google Scholar 

  8. Johnson RN, Blankenship GW (1988) A prospective, randomized, clinical trial of heparin therapy for postoperative intraocular fibrin. Ophthalmology 95:312–317

    Google Scholar 

  9. Lewis H, Abrams GW, William GA (1987) Anterior hyaloidal fibrovascular proliferation after diabetic vitrectomy. Am J Ophthalmol 104:607–613

    Google Scholar 

  10. Machemer R (1987) Massive periretinal proliferation: a logical approach to therapy. Trans Am Ophthalmol Soc 75:556–586

    Google Scholar 

  11. McCuen BW, Bessler M, Tano Y, Chandler D, Machemer R (1981) The lack of toxicity of intravitreally administered triamcinolone acetonide. Am J Ophthalmol 91:785–788

    Google Scholar 

  12. Sebestyen JG (1982) Fibrinoid syndrome. A severe complication of vitrectomy surgery in diabetics. Ann Ophthalmol 14:853–856

    Google Scholar 

  13. Tano Y, Sugita G, Abrams G, Machemer R (1980) Inhibition of intraocular proliferations with intravitreal corticosteroids. Am J Ophthalmol 89:131–136

    Google Scholar 

  14. Tano Y, Chandler D, Machemer R (1980) Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am J Ophthalmol 90:810–816

    Google Scholar 

  15. Vidaum-Leal JS, Glaser BM (1984) Effect of fibrin on morphologic characteristics of retinal pigment epithelial cells. Arch Ophthalmol 102:1376–1379

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Penn State University College of Medicine, P.O. Box 850, 17033, Hershey, PA, USA

    George William Blankenship

Authors
  1. George William Blankenship
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This project was supported in part by patients and contributors of the Departments of Ophthalmology, University of Miami School of Medicine and Penn State University College of Medicine; Research to Prevent Blindness, Inc., New York City; Pennsylvania Lions Vision and Research Center; and the Breen Green Diabetic Retinopathy Fund, Miami, Florida

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blankenship, G.W. Evaluation of a single intravitreal injection of dexamethasone phosphate in vitrectomy surgery for diabetic retinopathy complications. Graefe's Arch Clin Exp Ophthalmol 229, 62–65 (1991). https://doi.org/10.1007/BF00172263

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00172263

Keywords

Search

Navigation